VitalHub Corp. Reports First Quarter 2023 Results
12 May 2023 - 9:35AM
VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI)
(OTCQX:VHIBF) announced today it has filed its Interim Condensed
Consolidated Financial Statements and Management's Discussion and
Analysis report for the three months ended March 31, 2023, with the
Canadian securities authorities. These documents may be viewed
under the Company’s profile at www.sedar.com.
“We began 2023 with record first-quarter revenue
with continued robust positive year-over-year and sequential
momentum,” said Dan Matlow, Chief Executive Officer of VitalHub.
“Positive organic growth (17%) and accretive inorganic growth
contributed to our 34% Q1 2023 revenue increase. Strong
double-digit year-over-year growth in term licences, maintenance
and support, and triple digit growth in services and hardware, more
than offset the year-over-year decline in perpetual licenses. We
announced the acquisition of Coyote Software Corporation, our
sixteenth acquisition since 2017. ARR (1,2) benefited from positive
organic and inorganic growth and benefited from a gain due to the
increase in the value of the GBP pound relative to the CAD dollar
from Q4 2022. ARR (1,2) increased 65% or $15.6 million to $39.6
million from Q1 2022. Adjusted EBITDA (2) was strong at $2.9
million, representing 23% of revenue. We closed the quarter with
$17.2 million in cash on hand and, combined with the availability
of a Bank of Nova Scotia Facility, we currently have $50.2 million
at our disposal for operations and to continue progressing our
acquisition strategy. As evidenced by recent announcements
(relating to SHREWD, TREAT and College of Optometrists), we are
penetrating deeper into core accounts and expanding horizontally
into adjacent markets and look forward to continuing this momentum
in 2023.”
VitalHub Corp’s quarterly investor conference
call will take place on Friday, May 12, 2023, at 9:00AM EST.
To register for the call, please
visit:
https://us02web.zoom.us/webinar/register/WN_bMoJBht7Qs-pE3QBPf0QxQ
First Quarter
2023 Highlights
- Revenue of $12,595,174, an increase
of $3,171,983 or 34% from the Q1 2022.
- Gross profit as a percentage of
revenue for Q1 2023 was 80% as compared to 84% in Q1 2022 (Q4 2022
- 82%). The decrease in Q1 2023 was due to the unusual volume of
high margin perpetual license sales of $2,767,253 in Q1 2022, as
compared to $310,398 in Q1 2023.
- ARR (1, 2) at the end of Q1 2023
was $39,634,517.
- ARR (1, 2) growth consists of
$1,462,727 or 4% organic growth, $1,100,000 or 3% from acquisitions
(Coyote Software Corporation), and $926,600 or 3% of foreign
exchange changes from Q4 2022.
- ARR (1, 2) for Q1 2023 grew by
$15,619,427 or 65% from Q1 2022, and $3,489,367 or 10% from Q4
2022.
- EBITDA (2) of $1,987,747 compared
to $2,367,044 in the prior comparative quarter (Q4 2022 -
$470,220).
- Adjusted EBITDA (2) of $2,923,780,
or 23% of revenue, compared to $3,051,015, or 32% of revenue, in
the prior comparative quarter. (Q4 2022 - $1,306,717 or 22% of
revenue)
- The decrease was primarily
attributable to the aforementioned unusual volume of high margin
perpetual license sales in Q1 2022.
- Cash on hand at March 31, 2023, was
$17,167,716 compared to $17,452,210 as at December 31, 2022.
- Cash from operations before changes
in working capital was $1,476,785 for the period as compared to
$2,498,320 for the same period last year.
- Net income before income taxes of
$780,428 for Q1 2023 compared to $1,563,512 in Q1 2022 (Q4 2022 -
$1,306,717).
- The decrease was primarily
attributable to the aforementioned unusual volume of high margin
perpetual license sales in Q1 2022.
(1)
The Company defines
annual recurring revenue (“ARR”) as the recurring revenue expected
based on yearly subscriptions.(2)
Non-IFRS
measure.
Q1 2023 Results
|
Three months ended |
|
March 31, 2023 |
% Revenue |
March 31, 2022 |
% Revenue |
Change |
|
$ |
|
$ |
|
% |
Revenue |
12,595,174 |
|
100 |
% |
9,423,191 |
|
100 |
% |
34 |
% |
|
|
|
|
|
|
Cost of sales |
2,471,877 |
|
20 |
% |
1,474,579 |
|
16 |
% |
(68 |
%) |
|
|
|
|
|
|
Gross profit |
10,123,297 |
|
80 |
% |
7,948,612 |
|
84 |
% |
27 |
% |
|
|
|
|
|
|
Operating expenses |
|
|
|
|
|
General and administrative |
3,611,092 |
|
29 |
% |
1,845,516 |
|
20 |
% |
(96 |
%) |
Sales and marketing |
1,281,665 |
|
10 |
% |
1,048,389 |
|
11 |
% |
(22 |
%) |
Research and development |
2,520,021 |
|
20 |
% |
2,024,367 |
|
21 |
% |
(24 |
%) |
Depreciation of property and equipment |
75,283 |
|
1 |
% |
43,317 |
|
0 |
% |
(74 |
%) |
Depreciation of right-of-use assets |
95,907 |
|
1 |
% |
63,389 |
|
1 |
% |
(51 |
%) |
Stock based compensation |
277,684 |
|
2 |
% |
269,244 |
|
3 |
% |
(3 |
%) |
Foreign currency gain |
(213,261 |
) |
(2 |
%) |
(20,675 |
) |
(0 |
%) |
(931 |
%) |
|
|
|
|
|
|
Other income and expenses |
|
|
|
|
|
Amortization of intangible assets |
1,054,247 |
|
8 |
% |
683,928 |
|
7 |
% |
(54 |
%) |
Business acquisition, restructuring and integration
costs |
658,349 |
|
5 |
% |
414,727 |
|
4 |
% |
(59 |
%) |
Interest expense and accretion (net of interest
income) |
(38,987 |
) |
(0 |
%) |
(4,720 |
) |
(0 |
%) |
(726 |
%) |
Interest expense from lease liabilities |
20,869 |
|
0 |
% |
17,618 |
|
0 |
% |
(18 |
%) |
|
|
|
|
|
|
Current and deferred income taxes |
618,260 |
|
5 |
% |
125,901 |
|
1 |
% |
(391 |
%) |
|
|
|
|
|
|
Net income |
162,168 |
|
1 |
% |
1,437,611 |
|
15 |
% |
(89 |
%) |
|
|
|
|
|
|
EBITDA (Non-IFRS measure) |
1,987,747 |
|
16 |
% |
2,367,044 |
|
25 |
% |
(16 |
%) |
|
|
|
|
|
|
Adjusted EBITDA (Non-IFRS measure) |
2,923,780 |
|
23 |
% |
3,051,015 |
|
32 |
% |
(4 |
%) |
|
|
|
|
|
|
Annual recurring revenue (Non-IFRS measure) |
39,634,517 |
|
|
24,015,090 |
|
|
65 |
% |
|
|
|
|
|
|
Term licences, maintenance and support
revenue |
9,997,484 |
|
79 |
% |
5,732,891 |
|
61 |
% |
74 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at |
|
|
|
|
March 31, 2023 |
December 31, 2022 |
|
|
|
|
$ |
$ |
Deferred revenue |
|
|
|
16,671,903 |
|
15,495,461 |
|
|
|
|
|
|
|
Cash balance |
|
|
|
17,167,716 |
|
17,452,210 |
|
ABOUT VITALHUB
Software for Health and Human Services providers
designed to simplify the user experience and optimize outcomes.
VitalHub provides technology to Health and Human
Services providers including; Hospitals, Regional Health
Authorities, Mental Health, Long Term Care, Home Health, Community
and Social Services. VitalHub solutions span the categories of
Electronic Health Record (EHR), Case Management, Care Coordination,
Patient Flow & Operational Visibility, and DOCit Mobile Apps.
The Company has a robust two-pronged growth strategy, targeting
organic growth opportunities within its product suite, and pursuing
an aggressive M&A plan. Currently, VitalHub serves 600+ clients
across Canada, USA, UK, Australia, Qatar, and Latvia. VitalHub is
based in Toronto, Canada, with an offshore development hub in Sri
Lanka. The Company is publicly traded on the TSX Venture Exchange
under the symbol “VHI”.
CAUTIONARY STATEMENT
Certain statements contained in this news
release may constitute "forward-looking information" or "financial
outlook" within the meaning of applicable securities laws that
involve known and unknown risks, uncertainties and other factors
which may cause the actual results, performance or achievements to
be materially different from any future results, performance or
achievements expressed or implied by such forward-looking
information or financial outlook. Often, but not always,
forward-looking statements can be identified by the use of words
such as "plans", "is expected", "expects", "scheduled", "intends",
"contemplates", "anticipates", "believes", "proposes" or variations
(including negative variations) of such words and phrases, or state
that certain actions, events or results "may", "could", "would",
"might" or "will" be taken, occur or be achieved. Such statements
are based on the current expectations of the management of each
entity and are based on assumptions and subject to risks and
uncertainties. Although the management of each entity believes that
the assumptions underlying these statements are reasonable, they
may prove to be incorrect. Although the Company has attempted to
identify important factors that could cause actual actions, events
or results to differ materially from those described in
forward-looking statements, there may be other factors that cause
actions, events or results to differ from those anticipated,
estimated or intended. No forward-looking statement can be
guaranteed. Except as required by applicable securities laws,
forward-looking statements speak only as of the date on which they
are made and the Company undertakes no obligation to publicly
update or revise any forward-looking statement, whether as a result
of new information, future events, or otherwise.
CONTACT INFORMATION
Dan MatlowChief Executive Officer, Director(416)
727-9061dan.matlow@VitalHub.com
Vitalhub (TSX:VHI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Vitalhub (TSX:VHI)
Historical Stock Chart
From Jan 2024 to Jan 2025